The National Center for Tumor Diseases Dresden (NCT/UCC) is a joint institution of the German Cancer Research Center, the Carl Gustav Carus Faculty of Medicine at TU Dresden, the University Hospital Carl Gustav Carus Dresden and the Helmholtz-Zentrum Dresden-Rossendorf (HZDR). It combines interdisciplinary patient care with excellent cancer research beneath the same roof.
NCT/UCC Dresden in brief
Aim
We want to translate promising concepts from cancer research into patient care and cancer prevention, in order to stimulate studies and to develop new treatment and prevention strategies. The aim is to develop an individualized cancer medicine with targeted therapies for each individual patient.
History of cancer research and treatment in Dresden
2003
Founding of the University Cancer Center (UCC) as a multidisciplinary center for tumor treatment, cancer research and education.
2004
The "OncoRay - Center for Radiation Research in Oncology" is included in the funding program "Centers for Innovation Competence: Create Excellence - Foster Talents" by the Federal Ministry of Education and Research (BMBF)
2005
Start of the Collaborative Research Center 655: "Cells into tissues: Stem cell and progenitor commitment and interactions during tissue formation"
2007
UCC is awarded the title "Oncological Center of Excellence" by the German Cancer Aid. This award has been renewed with every assessment ever since.
2010
Germany's first partner site of the Cancer Information Service (KID) by the German Cancer Research Center (DKFZ) is established in Dresden.
OncoRay is named "National Center for Radiation Research in Oncology" jointly with the Heidelberg Institute for Radiooncology (HIRO)
2012
Dresden becomes a partner of the German Cancer Consortium.
2014
The Federal Minister of Research announces Dresden to be the partner site of NCT Heidelberg.
2015
The establishment of NCT/UCC Dresden begins.
2019
In summer of 2019, the DKFZ founded Germany's first DKFZ external site in Dresden.
2020
Opening of the new NCT/UCC building
Clinical Trials
- currently more than 300 oncological clinical studies
Research
Quality
- evidence-based guidelines for diagnostics, therapy and post-therapy
- up to 19 interdisciplinary tumor boards weekly
- core units:
NCT Unit for Molecular Tumor Diagnostics, Data Managment and Analytics, Immune Monitoring Unit, Preclinical Model Unit
Directorate
The directorate of the NCT/UCC Dresden
Prof. Dr. Martin Bornhäuser - Managing Director
Contact
Tel.: +49 (0)351 458 4704
E-Mail: martin.bornhaeuser(at)uniklinikum-dresden.de
Prof. Dr. Mechthild Krause - Managing Director
Contact
Tel.: +49 (0)351 458 5292
E-Mail: mechthild.krause(at)uniklinikum-dresden.de
Prof. Dr. Jürgen Weitz - Managing Director
Contact
Tel.: +49 (0)351 458 2742
Fax: +49 (0)351 458 4395
E-Mail: juergen.weitz(at)uniklinikum-dresden.de
Prof. Dr. Dr. h. c. Michael Baumann - Founding Director
Contact
Tel.: +49 (0)6221 42 2850
E-Mail: michael.baumann(at)dkfz-heidelberg.de
Dr. Heidrun Groß
Head of the coordination office NCT/UCC Dresden
Fetscherstraße 74/PF 64
01307 Dresden
Tel.: +49 (0)351 458 5239
Fax: +49 (0)351 458 5716
E-Mail: heidrun.gross(at)nct-dresden.de